303 related articles for article (PubMed ID: 6183193)
1. Biological Response Modifiers Programme and cancer chemotherapy.
Oldham RK
Int J Tissue React; 1982; 4(3):173-88. PubMed ID: 6183193
[TBL] [Abstract][Full Text] [Related]
2. Biologicals and biological response modifiers: fourth modality of cancer treatment.
Oldham RK
Cancer Treat Rep; 1984 Jan; 68(1):221-32. PubMed ID: 6198081
[TBL] [Abstract][Full Text] [Related]
3. Biological response modifiers.
Oldham RK
J Natl Cancer Inst; 1983 May; 70(5):789-96. PubMed ID: 6188871
[TBL] [Abstract][Full Text] [Related]
4. Cancer therapy by biological response modifiers.
Herberman RB
Arzneimittelforschung; 1987 Feb; 37(2A):246-50. PubMed ID: 2436633
[TBL] [Abstract][Full Text] [Related]
5. The NCI preclinical screen of biological response modifiers.
Talmadge JE; Fidler IJ; Oldham RK
Behring Inst Mitt; 1984 May; (74):189-94. PubMed ID: 6206841
[TBL] [Abstract][Full Text] [Related]
6. Design of clinical trials with biological response modifiers.
Herberman RB
Cancer Treat Rep; 1985 Oct; 69(10):1161-4. PubMed ID: 2412692
[TBL] [Abstract][Full Text] [Related]
7. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
Baxevanis CN; Perez SA; Papamichail M
Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
[TBL] [Abstract][Full Text] [Related]
8. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
9. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
10. [Present status of studies on the application of immunology to the diagnosis and therapy of cancer, with emphasis on monoclonal antibodies and cytokines].
Tokunaga T
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1358-66. PubMed ID: 3296954
[TBL] [Abstract][Full Text] [Related]
11. Bio-immunotherapy for cancer in experimental studies and clinical application: current status and future challenges.
Shen RN; Lu L; Kaiser HE; Broxmeyer HE
In Vivo; 1994; 8(5):643-52. PubMed ID: 7727711
[TBL] [Abstract][Full Text] [Related]
12. Practical considerations for the establishment of a screening procedure for the assessment of biological response modifiers.
Talmadge JE; Oldham RK; Fidler IJ
J Biol Response Mod; 1984; 3(1):88-109. PubMed ID: 6707701
[TBL] [Abstract][Full Text] [Related]
13. Assessment of biological responses: what to measure and when.
Maluish AE; Herberman RB
Cancer Treat Rep; 1985 Oct; 69(10):1165-9. PubMed ID: 3899356
[TBL] [Abstract][Full Text] [Related]
14. Future directions in the therapy for large bowel cancer.
Carter SK
Cancer; 1982 Dec; 50(11 Suppl):2647-56. PubMed ID: 6182979
[TBL] [Abstract][Full Text] [Related]
15. Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer?
Zöller M; Matzku S
Arch Immunol Ther Exp (Warsz); 2002; 50(3):197-224. PubMed ID: 12098935
[TBL] [Abstract][Full Text] [Related]
16. [Methods for evaluating biological response modifiers].
Harousseau JL
Bull Cancer; 1998 Dec; 85(12):993-6. PubMed ID: 9917552
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic activity in cancer of IL-2 in combination with other cytokines.
Truitt GA; Brunda MJ; Levitt D; Anderson TD; Sherman MI
Cancer Surv; 1989; 8(4):875-89. PubMed ID: 2701733
[TBL] [Abstract][Full Text] [Related]
18. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
Greenwald P
J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
[TBL] [Abstract][Full Text] [Related]
19. Lymphokines, monoclonal antibodies, and other biological response modifiers in the treatment of cancer.
Oldham RK; Thurman GB; Talmadge JE; Stevenson HC; Foon KA
Cancer; 1984 Dec; 54(11 Suppl):2795-806. PubMed ID: 6437660
[TBL] [Abstract][Full Text] [Related]
20. Twelve immunotherapy drugs that could cure cancers.
Cheever MA
Immunol Rev; 2008 Apr; 222():357-68. PubMed ID: 18364014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
